ArticleCureus2025
Epidemiology of Macrovascular and Microvascular Complications Among Patients With Diabetes Mellitus in Primary Care in Bahrain.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diabetes Burden in the Middle East and North Africa Region, 1990-2023: An Ecological Time-Trend Analysis of GBD Estimates.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Although diabetes mellitus (DM) is a leading cause of cardiovascular complications, few studies have evaluated the epidemiology of these complications in primary care in Bahrain. Since data from primary care settings are particularly important, as most patients with diabetes are managed in this setting, this study aimed to determine the prevalence and predictors of diabetic complications among patients attending primary healthcare centers in Bahrain. Methods A cross-sectional study was conducted among adult patients with DM attending diabetic clinics in primary care centers across Bahrain. Demographic, clinical, and laboratory data, and diabetes complications were collected. Microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (stroke, acute coronary syndrome, peripheral arterial disease) complications were assessed. Descriptive and inferential analyses were performed. Results A total of 585 patients were enrolled, with a median age of 61±14 years. Most patients were males (n=326, 55.7%), had type 2 DM (n=566, 96.8%), and had uncontrolled diabetes (n=349, 59.7%). Approximately half of the patients (51.6%) had at least one diabetes-related complication. Neuropathy (n=158, 27.0%) and retinopathy (n=89, 15.2%) were the most frequent microvascular complications, while peripheral vascular disease (n=64, 10.9%) and ischemic heart disease (n=61, 10.4%) were the leading macrovascular complications. Multivariable analysis revealed that higher total cholesterol (OR=1.326, p=0.031) and lower estimated glomerular filtration rate, eGFR (OR=1.009, p=0.025) predicted macrovascular complications. Diabetic foot ulcers increased macrovascular complications by 14-fold (p<0.001). Predictors of microvascular complications included type 2 DM (OR=16.277, p=0.011), longer DM duration (OR=1.156, p<0.001), higher triglycerides (OR=1.222, p=0.045), dyslipidemia (p=0.036), and foot ulcers (27-fold; p=0.002). Conclusion Diabetic complications were prevalent among diabetic patients in Bahrain, especially those with impaired renal function, dyslipidemia, anemia, and foot ulcers. Early identification and management of these comorbidities is crucial to prevent diabetes-related complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.